These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4562660)

  • 1. The medical treatment of angina pectoris. II. Design of an antianginal drug study.
    Aronow WS
    Am Heart J; 1972 Jul; 84(1):132-4. PubMed ID: 4562660
    [No Abstract]   [Full Text] [Related]  

  • 2. Practolol--an analysis of clinical trials in angina pectoris.
    Wiseman RA
    Acta Cardiol; 1972; Suppl 16():29-42. PubMed ID: 4405743
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of the ergometrine test for the diagnosis of ischemic heart disease and the choice of antianginal treatment].
    Voronkov LG; Remizovskiĭ GA
    Vrach Delo; 1991 Sep; (9):90-2. PubMed ID: 1759443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diltiazem in chronic stable angina].
    González-Hermosillo JA; Clemente AC; Salazar E
    Arch Inst Cardiol Mex; 1986; 56(4):327-32. PubMed ID: 2945527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sustained action isosorbide dinitrate on exercise performance in patients with ischemic heart disease.
    Brunner D; Meshulam N; Zerieker F
    Acta Cardiol; 1974; 29(4):281-93. PubMed ID: 4607749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ergometry as a method of evaluation of antianginal drugs].
    Piña López-Yllana C
    Arch Farmacol Toxicol; 1979 Dec; 5(3):231-4. PubMed ID: 546345
    [No Abstract]   [Full Text] [Related]  

  • 8. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical-cycloergometric correlation].
    Maranhão MF; Lopes M; Toledo MT; Rojas RI; Michelotto PV; Michelotto PV; Lacerda FS; Furlan L; Cunha GP; Oliveira PF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():95-9. PubMed ID: 329814
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of perhexiline maleate in patients with angina pectoris unrelieved by other antianginal agent.
    Alcocer L; Aspe J; Arce-Gomez E
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):349-57. PubMed ID: 4198295
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
    Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
    [No Abstract]   [Full Text] [Related]  

  • 11. Does placebo improve indexes of effort-induced myocardial ischemia? An objective study in 150 patients with chronic stable angina pectoris.
    Khurmi NS; Bowles MJ; Kohli RS; Raftery EB
    Am J Cardiol; 1986 Apr; 57(11):907-11. PubMed ID: 3515895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of angina pectoris with alpha methyldopa.
    Frederiksen RT; Cheitlin MD; Ferguson DR
    Am Heart J; 1974 Jul; 88(1):47-50. PubMed ID: 4600690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of many hours of ECG monitoring (Holter method) in the diagnosis of ischemic heart disease and the selection and evaluation of antianginal therapy].
    Sidorenko BA; Komar OA; Liakishev AA; Batyrbekova LM; Kulikova TV
    Kardiologiia; 1985 Sep; 25(9):31-7. PubMed ID: 3908780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological aspects of clinical evaluation of antianginal drugs.
    Jasiński K; Wierzchowiecki M; Poprawski K
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):368-71. PubMed ID: 357310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
    Liljedal J
    Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation of verapamil in the treatment of angina pectoris.
    Sandler G
    Brux Med; 1970 Sep; 50(9):669-73. PubMed ID: 4928626
    [No Abstract]   [Full Text] [Related]  

  • 17. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of acute digitalization to influence exercise tolerance in angina pectoris.
    Smith HJ; Bousvaros GA; McGregor M
    Br Med J; 1966 May; 1(5499):1337-8. PubMed ID: 5327222
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol.
    Frishman WH; Weksler B; Christodoulou JP; Smithen C; Killip T
    Circulation; 1974 Nov; 50(5):887-96. PubMed ID: 4609635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.